Industrial Microbiology Testing Services Market Size Set to Hit USD 8.2 Bn by 2033
The global industrial microbiology testing services market size was estimated at USD 3.32 billion in 2023 and it is expected to surpass around USD 8.2 billion by 2033, poised to grow at a CAGR of 9.46% from 2024 to 2033.
Industrial microbiology testing services play a crucial role in ensuring the safety and quality of products across various industries, including food and beverages, pharmaceuticals, cosmetics, and environmental monitoring. These services encompass a wide range of microbiological analyses aimed at detecting and identifying potential contaminants, pathogens, and spoilage organisms.
The growth of the industrial microbiology testing services market is propelled by the stringent regulatory requirements across industries such as food and beverages, pharmaceuticals, and cosmetics drive the demand for microbiological testing to ensure compliance and consumer safety. Additionally, heightened consumer awareness regarding product quality and safety further fuels market growth. Technological advancements, particularly in rapid microbiological methods (RMM) and automation, enhance the efficiency and accuracy of testing services, driving adoption. Moreover, the increasing emphasis on preventive healthcare and the need for stringent quality control measures contribute to the expansion of the market.
| Report Coverage | Details |
| Revenue Share of North America in 2023 | 46% |
| CAGR of Asia Pacific from 2024 to 2033 | 10.67% |
| Revenue Forecast by 2033 | USD 8.2 billion |
| Growth Rate from 2024 to 2033 | CAGR of 9.46% |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
On the basis of test types, the global industry has been further categorized into sterility testing, microbial limits testing, bio-burden testing, water testing, air monitoring tests, and others. The sterility testing segment led the market in 2023 and accounted for the largest share of 33% of the overall revenue. Factors, such as increased research & development in life sciences and a rise in the number of medicine launches, are driving the market expansion. Furthermore, the rising global demand for sterilized products, as well as a few potential safety issues associated with the products, which usually arise from manufacturing processes that involve complicated biological and structural characteristics, are expected to drive market growth over the forecast period.
On the other hand, the microbial limits testing segment is estimated to witness the fastest growth rate of 12.75% during the forecast period. The rising prevalence of chronic & infectious diseases, together with the growing demand for packaged food & beverage products, increases the demand for microbiological limit testing services to ensure product safety. This is expected to drive the expansion of the overall market during the forecast period.
The pharmaceutical & biotechnology end-use segment dominated the global industry in 2023 and accounted for the largest share of 31% of the overall revenue. In the pharmaceutical and biotechnology industries, quality must be maintained during the manufacturing process. These requirements are upheld by a variety of means, one of which is the environmental monitoring procedure, which determines the quality & sterility of the controlled manufacturing environment.
On the other hand, the food & beverage end-use segment is estimated to witness the fastest growth rate of 11.55% during the forecast period. The rise in cases of food-borne illnesses, growing consumer awareness about food safety, the implementation of strict food safety standards, and rising customer demand for convenience & packaged food products are all driving the market expansion. For instance, according to the CDC estimates, each year in the U.S., 48 million people become ill, 128,000 receive medical treatment, and 3,000 die as a result of foodborne infections.
North America accounted for the largest share of 46% of the overall revenue in 2023. The presence of major companies from industries including pharma and biotechnology, as well as food and drinks, is the primary indicator of the largest market share. In addition, present competitors are undertaking initiatives to develop industrial testing capabilities in a variety of applications. Perfectus Biomed Group, a CRO established in the U.S. and the UK, was bought by NAMSA in October 2023. This acquisition intends to improve customized microbiological services while also establishing a global footprint through 20 lab locations in the U.S., Europe, and Asia.
The Asia Pacific regional market is expected to experience the fastest growth rate of 10.67% from 2024 to 2033 due to improved healthcare infrastructure, improving economic factors, an increase in government efforts to raise awareness, as well as favorable regulatory policies that will boost the rate of adoption for industrial microbiology testing services. Furthermore, the region's increased need for high-quality healthcare has a favorable impact on industry growth.
By Test Type
By End-use
By Region
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Industrial Microbiology Testing Services Market
5.1. COVID-19 Landscape: Industrial Microbiology Testing Services Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Industrial Microbiology Testing Services Market, By Test Type
8.1. Industrial Microbiology Testing Services Market, by Test Type, 2024-2033
8.1.1. Sterility Testing
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Microbial Limits Testing
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Bio-burden Testing
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Water Testing
8.1.4.1. Market Revenue and Forecast (2021-2033)
8.1.5. Air Monitoring Tests
8.1.5.1. Market Revenue and Forecast (2021-2033)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Industrial Microbiology Testing Services Market, By End-use
9.1. Industrial Microbiology Testing Services Market, by End-use, 2024-2033
9.1.1. Food & Beverages
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Pharmaceutical & Biotechnology
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Agricultural
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Environmental
9.1.4.1. Market Revenue and Forecast (2021-2033)
9.1.5. Cosmetic and Personal Care
9.1.5.1. Market Revenue and Forecast (2021-2033)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Industrial Microbiology Testing Services Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Test Type (2021-2033)
10.1.2. Market Revenue and Forecast, by End-use (2021-2033)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Test Type (2021-2033)
10.1.3.2. Market Revenue and Forecast, by End-use (2021-2033)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Test Type (2021-2033)
10.1.4.2. Market Revenue and Forecast, by End-use (2021-2033)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Test Type (2021-2033)
10.2.2. Market Revenue and Forecast, by End-use (2021-2033)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Test Type (2021-2033)
10.2.3.2. Market Revenue and Forecast, by End-use (2021-2033)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Test Type (2021-2033)
10.2.4.2. Market Revenue and Forecast, by End-use (2021-2033)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Test Type (2021-2033)
10.2.5.2. Market Revenue and Forecast, by End-use (2021-2033)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Test Type (2021-2033)
10.2.6.2. Market Revenue and Forecast, by End-use (2021-2033)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Test Type (2021-2033)
10.3.2. Market Revenue and Forecast, by End-use (2021-2033)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Test Type (2021-2033)
10.3.3.2. Market Revenue and Forecast, by End-use (2021-2033)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Test Type (2021-2033)
10.3.4.2. Market Revenue and Forecast, by End-use (2021-2033)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Test Type (2021-2033)
10.3.5.2. Market Revenue and Forecast, by End-use (2021-2033)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Test Type (2021-2033)
10.3.6.2. Market Revenue and Forecast, by End-use (2021-2033)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Test Type (2021-2033)
10.4.2. Market Revenue and Forecast, by End-use (2021-2033)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Test Type (2021-2033)
10.4.3.2. Market Revenue and Forecast, by End-use (2021-2033)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Test Type (2021-2033)
10.4.4.2. Market Revenue and Forecast, by End-use (2021-2033)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Test Type (2021-2033)
10.4.5.2. Market Revenue and Forecast, by End-use (2021-2033)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Test Type (2021-2033)
10.4.6.2. Market Revenue and Forecast, by End-use (2021-2033)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Test Type (2021-2033)
10.5.2. Market Revenue and Forecast, by End-use (2021-2033)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Test Type (2021-2033)
10.5.3.2. Market Revenue and Forecast, by End-use (2021-2033)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Test Type (2021-2033)
10.5.4.2. Market Revenue and Forecast, by End-use (2021-2033)
Chapter 11. Company Profiles
11.1. Charles River Laboratories
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Intertek Group Plc
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Spectro Analytical Labs Pvt. Ltd.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Pacelabs
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. LTE Scientific
11.5. Biotech Testing Services
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Merck KGaA
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. TÜV SÜD
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Precise Analytics Lab
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Eurofins Scientific
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Biocare Research (India) Pvt. Ltd.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers